Tekla Life Sciences Investors (HQL) — Cash Flow Quality Index
Tekla Life Sciences Investors (HQL) has a Cash Flow Quality Index of -0.01x as of September 2025. Operating cash flow of $-1.28 Million is below net income of $132.83 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Tekla Life Sciences Investors long-term investment allocation to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Tekla Life Sciences Investors Cash Flow Quality Index (1996–2025)
Historical Cash Flow Quality Index for Tekla Life Sciences Investors across 14 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check how tangible is Tekla Life Sciences Investors's equity to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Tekla Life Sciences Investors (1996–2025)
Year-by-year earnings quality comparison for Tekla Life Sciences Investors. For live market cap and the full company financial profile, see HQL stock market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | -0.03x | $-2.32 Million | $85.59 Million | ▼ -236288.4% |
| 2021 | 0.00x | $-0.74 | $64.53K | ▲ +100.0% |
| 2014 | -0.59x | $-52.57K | $89.27K | ▼ -626.2% |
| 2013 | 0.11x | $9.47K | $84.64K | ▼ -58.8% |
| 2012 | 0.27x | $21.11 Million | $77.63 Million | ▼ -91.4% |
| 2011 | 3.16x | $118.30 Million | $37.47 Million | ▲ +1593.3% |
| 2010 | 0.19x | $1.90 Million | $10.19 Million | ▼ -4.8% |
| 2008 | 0.20x | $11.80 Million | $60.25 Million | ▲ +367.4% |
| 2007 | -0.07x | $-3.70 Million | $50.51 Million | ▼ -2.5% |
| 2005 | -0.07x | $-3.20 Million | $44.76 Million | ▲ +84.0% |
| 2004 | -0.45x | $-3.20 Million | $7.16 Million | ▼ -619.2% |
| 2003 | -0.06x | $-2.40 Million | $38.62 Million | ▲ +37.1% |
| 1997 | -0.10x | $-1.50 Million | $15.19 Million | ▼ -43.6% |
| 1996 | -0.07x | $-1.50 Million | $21.81 Million | — |